Hormone therapy market segments, hormone therapy market overview, hormone therapy market report, hormone therapy market share, hormone therapy market analysis, hormone therapy industry analysis, hormone therapy market forecast, hormone therapy market insights, hormone therapy market top players, hormone therapy market size, hormone therapy market growth
The hormone therapy global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Hormone Therapy Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The hormone therapy market size has grown strongly in recent years. It will grow from $18.58 billion in 2023 to $19.93 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to medical advancements, women’s health revolution, increased awareness and education, clinical research and development, shifting healthcare practices..
The hormone therapy market size is expected to see strong growth in the next few years. It will grow to $26.49 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to personalized medicine approach, aging population dynamics, shift in women’s health approaches, focus on wellness and longevity, regulatory adaptations.. Major trends in the forecast period include regulatory changes and guidelines, changing lifestyles and stress, research and development, expanding awareness and education..
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report
Scope Of Hormone Therapy Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Hormone Therapy Market Overview
Market Drivers –
A surge in the incidences of hormone imbalance disorders is significantly contributing to the growth of the hormone therapy market going forward. Hormone imbalance refers to the condition where the body produces either too much or too little of a hormone. Various hormone imbalance disorders include hypothyroidism, hypogonadism, growth hormone deficiency, and so on. Hormone therapies such as estrogen replacement, testosterone replacement, and insulin therapy are used to treat hormone imbalance disorders. For example, according to a 2022 report published by London Medical Laboratory, a UK-based provider of diagnostics and phlebotomy, 19% more people were expected to have significant hormone imbalances in 2022 compared to 2 years ago. Therefore, a surge in the incidence of hormone imbalance disorders will drive the hormone therapy market.
Market Trends –
Product innovation is the key trend gaining popularity in the hormone therapy market. Major companies operating in the hormone therapy market are focusing on launching new innovative treatments for hormone imbalance disorders and their symptoms to decrease side effects and introduce treatment for other symptoms. Such innovations enable key players to gain a competitive edge in the market. For instance, in May 2021, Myovant Sciences, a UK-based healthcare company, and Pfizer, a US-based biotechnology company, received FDA-approval for MYFEMBREE, a new once-daily medication administered for up to 24 months to manage premenopausal women’s excessive monthly bleeding brought on by uterine fibroids. MYFEMBREE provides clinically significant symptom alleviation for heavy menstrual bleeding in women with uterine fibroids with just one pill, taken once daily. For patients with commercial insurance, the MYFEMBREE Support Program offers services such as insurance benefit checks, prior authorization support, co-pay support, and patient assistance for eligible uninsured patients.
The hormone therapy market covered in this report is segmented –
1) By Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement
2) By Route of Administration: Oral, Parenteral, Other Routes of Administration
3) By Indication: Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies
Get an inside scoop of the hormone therapy market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=9246&type=smp
Regional Insights –
North America was the largest region in the hormone therapy market in 2023. The regions covered in the hormone therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Key Companies –
Major companies operating in the hormone therapy market report are Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., Abbvie Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company Plc., Cipla Inc., Lupin Limited, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Sanofi S.A., AstraZeneca plc, TherapeuticsMD Inc., Amgen Inc., Genentech Inc., Dr. Reddy’s Laboratories Ltd, Allergan PLC, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited .
Table of Contents
1. Executive Summary
2. Hormone Therapy Market Report Structure
3. Hormone Therapy Market Trends And Strategies
4. Hormone Therapy Market – Macro Economic Scenario
5. Hormone Therapy Market Size And Growth
…..
27. Hormone Therapy Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
